株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

商用バイオテクノロジー分離システムの世界市場

Commercial Biotechnology Separation Systems

発行 Global Industry Analysts, Inc. 商品コード 352667
出版日 ページ情報 英文 271 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.24円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
商用バイオテクノロジー分離システムの世界市場 Commercial Biotechnology Separation Systems
出版日: 2016年02月01日 ページ情報: 英文 271 Pages
概要

当レポートでは、世界の商用バイオテクノロジー分離システム市場について調査し、2014年から2020年までの市場成長見通し、地域別動向、および市場に参入する主な企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 今後の見通し
    • 分離技術がバイオテクノロジー業界を牽引
    • 先進国がリードするも新興市場が成長見込み
    • 液体クロマトグラフィがバイオテクノロジー分離技術をリード
  • 業界レビュー、動向、促進因子
    • バイオセパレーションシステム
    • バイオ医薬品製造のピーク
    • 生物学的合成製品の下流プロセス:概要
    • 成長するバイオ医薬品市場がバイオセパレーションシステムの需要を牽引 他
  • 分離技術:市場分析
  • 製品概要
    • バイオテクノロジー分離システム:概要
    • フローサイトメトリ:イントロダクション
    • クロマトグラフィー
    • 膜分離
    • バイオチップ
    • マイクロアレイ
    • 遠心分離
    • 電気泳動
  • 製品革新/導入
  • 近年の業界活動
  • 主要企業
    • 3M Purification, Inc.
    • AB Sciex
    • Affymetrix, Inc.
    • Agilent Technologies, Inc.
    • Alfa Laval AB
    • Alfa Wassermann Inc.
    • Atoll GmbH
    • Beckman Coulter, Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Flottweg SE
    • Fluidigm Corporation
    • GE Healthcare
    • Groupe Novasep
    • 日立工機株式会社
    • Illumina, Inc.
    • Merck KGaA
    • Pall Corporation
    • PerkinElmer, Inc
    • ProMetic Life Sciences, Inc.
    • Repligen Corporation
    • Sartorius Stedim Biotech SA
    • SEPMAG Technologies
    • Shimadzu Scientific Instruments
    • Spectrum Laboratories, Inc.
    • Sysmex Partec GmbH
    • Thermo Fisher Scientific, Inc.
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ

第4章 競合環境

目次
Product Code: MCP-7990

This report analyzes the worldwide markets for Commercial Biotechnology Separation Systems in US$. The Global market is further analyzed by the following Types: DNA Microarray, Flow Cytometry, Liquid Chromatography, Membrane Filtration, Protein Microarray, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 46 companies including many key and niche players such as -

3M Purification, Inc.
AB Sciex
Affymetrix, Inc.
Agilent Technologies, Inc.
Alfa Laval AB

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. OUTLOOK

  • Separation Technologies Drive Biotechnology Industry
  • Developed Markets Lead the Way while Emerging Markets Promise Growth
  • Liquid Chromatography Leads Biotechnology Separation Technologies

2. INDUSTRY OVERVIEW, TRENDS & DRIVERS

  • Bioseparation Systems - Invaluable Tools in Biopharmaceutical Manufacturing
  • A Peek into Biopharmaceutical Manufacturing
  • Downstream Processing of Biosynthetic Products - An Overview
  • Growing Biopharmaceuticals Market Drives Demand for Bioseparation Systems
  • 2014-15: A Launch-Driven Period for Biopharmaceuticals
    • Recently Approved Biopharmaceuticals: 2013, 2014 & 2015
  • Evolving Biopharmaceutical Industry Emphasizes on Novel Technologies
  • Increasing Competition Spurs Renewed Focus on Efficiencies
  • Growing Orphan Drugs Market Draws Attention towards Manufacturing Flexibility
  • Downstream Processing - A Major Trend among Biopharmaceutical Manufacturers
  • Upstream and Downstream Mismatch Turns Focus towards Innovative Technologies
  • Protein Separation in Biopharmaceutical Space Assumes Greater Significance
  • Growing Market for Monoclonal Antibodies - Review of Current Status and Future Prospects
  • Approved Monoclonal Antibodies for Therapeutic Use: 1986-2014
  • An Insight into Bioseparation of mAbs
  • Market Potential for Biosimilars - A Case for Substantial Demand for Separation Technologies
    • Table 1: Global Biosimilars Market in US$ Billion for 2012-2018 (includes corresponding Graph/Chart)
  • 2015: A Year of Patent Expiries for Biologics
    • Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
  • Huge Biopharmaceutical Pipeline - A Clear Indicator of Future Prospects
    • Table 2: Biopharmaceutical Products Pipeline by Therapeutic Category (2015) (includes corresponding Graph/Chart)
    • Table 3: Number of Pipeline Biopharmaceuticals for Cancer by Site (2015) (includes corresponding Graph/Chart)
    • Table 4: Number of Pipeline Biopharmaceuticals for HIV/AIDS Treatment by Type of Therapy (2015) (includes corresponding Graph/Chart)
  • Disposables to Infuse Cost Effectiveness in Biopharmaceutical Production
  • Single-Use Products Gain Significant Attention
  • Market Prospects for Single-Use Disposable Technologies
    • Select Commercial Disposable/Single-Use Technologies by Process Technique
  • Innovations in Single-use Systems
  • Modular Bioprocessing - An Emerging Trend
  • Leachables and Extractables Trounce Enthusiasm around Disposables

3. SEPARATION TECHNOLOGIES - MARKET ANALYSIS

  • Chromatography - the Gold Standard Separation and Purification Technology
  • Market Outlook
    • Ongoing Developments and Innovations Create Strong Demand for Columns
  • Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
  • Pre-packed Disposable Columns in Chromatography Gain Attention
    • Clinical Trials - the Largest Market for Pre-packed Disposable Columns
    • GE Leads Pre-packed Disposable Columns Market for Chromatography
    • Table 5: Leading Players in the Global Pre-packed, Disposable Columns for Chromatography (2014): Percentage Breakdown of Revenues for Atoll Bio, EMD-Millipore, GE Healthcare, Repligen and Others (includes corresponding Graph/Chart)
  • SMBC - An Old Approach Gaining Significant Attention
    • Major Advantages and Disadvantages of SMBC
  • Twin-Column SMB - An Emerging Alternative to Protein A Columns
  • Growing Focus on Alternatives to Protein A Chromatography
    • Precipitation and Crystallization - Techniques with Major Use in Protein Purification
      • Reversible Precipitation - A Novel Bioseparation Technology
  • Alternatives to Protein A-based Chromatography to See Significant Adoption
  • Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
  • Microarrays Witness Tremendous Growth
  • Protein Biochips - Set for Robust Expansion
  • Lab-on-a-Chip: Fusion of Nanotechnology & Genetic Engineering
  • Current Approaches to Biochips
  • Advancements in Biochip Technology
  • Technological Differentiation in Demand
  • Biochip Technology Boosts Personalized Medicine
  • Biochip Technology Spreads beyond Pharma Industry
  • Data on Specificity of Effect Drives Use of Microarrays in Cosmetics and Personal Healthcare
    • Need for Alternative Techniques - The Key Drawback
  • Membrane Separation - A Promising Separation Technology
  • Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
    • Membrane Adsorbers Gain Ground in Biopharmaceutical Downstream Purification
    • Prospering Vaccine Market Drives Use of Ultrafiltration Techniques
  • Membrane Filtration Gains Widespread Application in Food Industry
    • Membrane Separation in Dairy Industry
      • A Note on Applications of Select Other Membrane Technologies in Dairy Industry
      • Ultrafiltration - A Widely Used Technique for Mineral Separation from Milk Products
      • Polymeric Membrane-based Separations Gain Attention in Dairy Sector
      • Novel Techniques Emerge to Prevent Solubility of Milk Protein Concentrate
  • Flow Cytometry - A Key Laboratory Analytical Technology
  • Developing Countries Present Growth Opportunities
  • Cell-based Flow Cytometry Lead the Pack
  • Research & Clinical Laboratories - Largest End-Use Segments
    • A Gist of Major Growth Drivers
    • Growth Barriers/Key Challenges
  • Technological Advances Boost Cytometric System Sales
  • Novel Cytometers Advance Technological Evolution
  • Mass Cytometry - A New Technology in Flow Cytometry
  • Microfluidics Take Cell Sorting to a New Level
  • Flow Cytometer Faces Competition from Alternative Instruments
  • Increasing Role of Flow Cytometry in Disease Diagnosis
  • IVD Application Market Set to Rise
  • Large-Scale Screening Operations - Untapped Domain
  • Rising Use of Image Flow Cytometry in Clinical Applications
  • Rising HIV Prevalence Provides Growth Opportunities for POC Flow Cytometry
  • Competitive Scenario in the Global Flow Cytometry Market
    • Table 6: Leading Players in the Global Flow Cytometers Market (2013): Percentage Breakdown of Value Sales for Becton Dickinson and Company (BD), Danaher/Beckman Coulter, and Others (includes corresponding Graph/Chart)
  • Centrifugation - A Key Separation Technology in Biopharmaceutical Production
  • Growing Proteomic Research Drives Demand for Electrophoresis Equipment
  • Major Application Areas of Electrophoresis Equipment
    • Table 7: Global Capillary Electrophoresis Equipment Market by Application Sector (2013): Percentage Share Breakdown of Value Sales for Pharmaceutical, Bioscience, Chemical, Food/Beverages and Other Application Sectors (includes corresponding Graph/Chart)
  • Capillary Electrophoresis Gains Prominence
  • 2D Gel Electrophoresis Market Gains Ground
    • Overview of the 2D Gel Electrophoresis Market
    • Advent of 2D-DIGE
    • Table 8: World 2D Gel Electrophoresis Market by Segment (2013): Percentage Share Breakdown of Value Sales for Reagents, Instruments/ Apparatus and Informatics (includes corresponding Graph/Chart)
    • Factors Driving Growth of Two-Dimensional Gel Electrophoresis Market
  • Reconfigured by Technology
  • Product Innovations Sustain Sales
  • Advanced Gel-Imaging Systems: An Emerging Market with Promising Growth
  • High Level of Fragmentation Typifies Electrophoresis Competitive Landscape
  • Magnetic Separations - An Overview

4. PRODUCT OVERVIEW

  • Biotechnology Separation Systems - An Overview
  • Flow Cytometry - An Introduction
    • Flow Cytometers
      • Fluidics System
      • Optical System
      • Electronics System
    • Application Areas - An Overview
      • Versatile Use
      • Clinical Applications
      • Research Applications
      • Drug Discovery
      • Biomedical Research
      • Fetal Cell Separation
      • Stem Cell Sorting
      • Marine Biology and Environmental Sciences
      • Microbiology
  • Chromatography: A Popular Separation Technology
    • Liquid Chromatography - An Overview
      • General Scheme
      • Column Chromatography
      • Chromatography Components
      • Mobile Phase
      • Stationary Phase
      • Advantages and Disadvantages of Different Types of Liquid Chromatography
  • Membrane Separation
  • Biochips - Complex Blend of Biochemistry and Electronics
    • Classification of Biochips
  • Microarrays
  • Centrifuges - A Technical Overview
    • Batch and Semi-Batch Centrifugation
    • Types of Preparative Centrifuges
      • Tubular Bowl Centrifuge
      • Disk Stack Centrifuge
      • Chamber Bowl
      • Ultracentrifuge
      • Decanter Centrifuge
      • Centrifugal Filter
  • Electrophoresis
    • Types of Electrophoresis
      • Conventional/Gel Electrophoresis
      • Slab Gel Electrophoresis
      • Polyacrylamide Gel Electrophoresis (PAGE)
      • Two-Dimensional Gel Electrophoresis
      • Capillary Electrophoresis
      • Advantages of Capillary Electrophoresis Instruments
      • Enables Sizing of a Piece of DNA Down to a Single Base
      • Exhibits High Resolution and Fluorescently Labels Multiplexed PCR Products
      • Allow Rapid Separations Due to Generation of High Voltages
      • Produces Reliable Analysis Results
      • Allows Residual Disease Testing of Engraftment Studies of Bone Marrow Transplant
      • Allows Testing for FLT3 Mutation
      • Separation Techniques Employed in CE

5. PRODUCT INNOVATIONS/INTRODUCTIONS

  • EMD Millipore Launches Sterilizing-Grade Millipore Express(r) PHF Hydrophilic Filters
  • Novasep Unveils BioSC(r) Lab
  • EMD Millipore Unveils Pellicon(r) Tangential Flow Filtration System
  • ImmunoReagents and ProteoVec Launch PV-Pure Ig(tm) Antibody Purification Kits
  • BASF Launches PRODIAS Project in Collaboration with Eight Partners
  • AMSBIO Introduces MagSi-Direct for Bioseparations
  • EMD Millipore Rolls Out PureFlex(tm) Plus Disposable Process Container Film
  • EMD Millipore Rolls Out New Resins for Chromabolt(r) Chromatography Columns
  • Thermo Fisher Scientific Launches New Chromatography Resin
  • Thermo Fisher Scientific to Introduce GlycanPac AXR-1 Column at Pittcon 2014
  • Purolite to Develop Bioseparation Resins for Chromatography
  • EMD Millipore Unveils Innovative Single-Stage Clarification Clarisolve(r) Depth Filters
  • Novasep Rolls Out Sius(tm) Single-Use TFF Skid
  • Thermo Fisher Scientific Introduces New 3000 BioRS System
  • Thermo Fisher Scientific Launches SEC-300 and SEC-1000 HPLC Columns
  • EMD Millipore Introduces Smart Flexware(r) Assemblies Along with Mobius(r) FlexReady Solution

6. RECENT INDUSTRY ACTIVITY

  • Merck Acquires Sigma-Aldrich
  • Novasep and CPI Install BioSC Lab at UK National Biologics Manufacturing Centre
  • Anteo Diagnostics Inks South Korean Distribution Agreement with KomaBiotech
  • GE Healthcare and Sartorius Stedim Biotech Ink OEM Supply Agreement for Sartobind(tm) Technology
  • Pall Inks Exclusive License for AWS Technology from FDS
  • Novasep Inks Partnership with Allied Laboratories and AR Brown
  • Pall Acquires Tarpon's BioSMB Platform
  • Stora Enso Takes Over Virdia
  • Pall Corporation Acquires ATMI's Life Sciences Business Division
  • AB Sciex and Beckman Coulter Combine CE and Chromatography Businesses

7. FOCUS ON SELECT PLAYERS

  • 3M Purification, Inc. (US)
  • AB Sciex (US)
  • Affymetrix, Inc. (US)
  • Agilent Technologies, Inc. (US)
  • Alfa Laval AB (Sweden)
  • Alfa Wassermann Inc. (US)
  • Atoll GmbH (Germany)
  • Beckman Coulter, Inc. (US)
  • Becton, Dickinson and Company (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Flottweg SE (Germany)
  • Fluidigm Corporation (US)
  • GE Healthcare (UK)
  • Groupe Novasep (France)
  • Hitachi Koki Co., Ltd. (Japan)
  • Illumina, Inc. (US)
  • Merck KGaA (Germany)
  • Pall Corporation (US)
  • PerkinElmer, Inc. (US)
  • ProMetic Life Sciences, Inc. (Canada)
  • Repligen Corporation (US)
  • Sartorius Stedim Biotech SA (France)
  • SEPMAG Technologies (Spain)
  • Shimadzu Scientific Instruments (US)
  • Spectrum Laboratories, Inc. (US)
  • Sysmex Partec GmbH (Germany)
  • Thermo Fisher Scientific, Inc. (US)

8. GLOBAL MARKET PERSPECTIVE

    • Table 9: World Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 10: World Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 11: World 14-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 12: World Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Type - DNA Microarray, Flow Cytometry, Liquid Chromatography, Membrane Filtration, Protein Microarray and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 13: World Historic Review for Commercial Biotechnology Separation Systems by Type - DNA Microarray, Flow Cytometry, Liquid Chromatography, Membrane Filtration, Protein Microarray and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 14: World 14-Year Perspective for Commercial Biotechnology Separation Systems by Type - Percentage Breakdown of Revenues for DNA Microarray, Flow Cytometry, Liquid Chromatography, Membrane Filtration, Protein Microarray and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • United States: The Largest Biopharmaceutical Market Globally
    • Table 15: No. of Biologics Approved by the Center for Biologics Evaluation and Research (CBER): 2003-2013 (includes corresponding Graph/Chart)
    • Impending Patent Expiries Signal Growth Prospects
    • Table 16: Leading US Biopharmaceuticals by Revenue (in US$ Billion) and Year of Patent Expiry (includes corresponding Graph/Chart)
    • Select Trends in Biopharmaceutical Market
      • Manufacturers Shift Focus to Small Bioreactors
      • Biosimilar Drug Developers Face Higher Litigation Risks
    • US Flow Cytometry Market - An Overview
    • Table 17: Leading Players in the US Flow Cytometry Market (2014): Percentage Breakdown of Sales for Becton Dickinson, Beckman Coulter, and Others (includes corresponding Graph/Chart)
    • Growth in Protein Electrophoresis Segment to Persist
      • Factors Influencing Purchasing Decisions in Protein Electrophoresis Equipment Market
      • Major Factors Influencing Purchasing Decision for Protein Electrophoresis
      • Key Trends in the US PE Market
      • Ready-Made Gels Grow at the Expense of Hand-Cast Gels
    • Product Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 18: US Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 19: US Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current & Future Analysis
    • Canada - A Lucrative Biopharmaceutical Industry
    • Key Player
  • B. Market Analytics
    • Table 20: Canadian Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 21: Canadian Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
    • Key Player
  • B. Market Analytics
    • Table 22: Japanese Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 23: Japanese Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • European Biopharmaceutical Industry - Select Trends
      • Funding Challenges Faced by Biopharmaceutical Startups
      • Healthcare Agencies Looking to Embrace Biosimilars to Cut Healthcare Costs
  • B. Market Analytics
    • Table 24: European Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 25: European Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 26: European 14-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launches
    • Key Players
  • B. Market Analytics
    • Table 27: French Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 28: French Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
    • Key Players
  • B. Market Analytics
    • Table 29: German Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 30: German Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 31: Italian Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 32: Italian Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launch
    • Strategic Corporate Developments
    • Key Player
  • B. Market Analytics
    • Table 33: UK Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 34: UK Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current & Future Analysis
    • Key Player
  • B. Market Analytics
    • Table 35: Spanish Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 36: Spanish Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4f. RUSSIA

  • A. Market Analysis
    • Current & Future Analysis
    • Russia Sets Eyes on Emerging as a Notable Pharmaceutical Industry
    • Encouragement for Local Manufacturing to Drive Demand
    • Challenges - Need for Extensive R&D
  • B. Market Analytics
    • Table 37: Russian Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 38: Russian Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Key Player
  • B. Market Analytics
    • Table 39: Rest of Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 40: Rest of Europe Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Asia Set to Emerge as Preferred Outsourcing Destination for Biopharma Manufacturing
  • B. Market Analytics
    • Table 41: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 42: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 43: Asia-Pacific 14-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • Market Analysis
    • Table 44: Chinese Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 45: Chinese Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Current & Future Analysis
    • Favorable End-use Market Dynamics Drive Demand for Flow Cytometers
    • Table 46: Flow Cytometry Market in India (2014): Percentage Breakdown of Sales by End-Use Industry - Life Sciences, Clinical Research and Pharmaceutical (includes corresponding Graph/Chart)
    • Table 47: Indian Market for Flow Cytometers by Product (2013): Percentage Share Breakdown of Value Sales for Instruments and Reagents (includes corresponding Graph/Chart)
    • Table 48: Indian Market for Flow Cytometers Reagents (2013): Percentage Share Breakdown of Value Sales by Application (includes corresponding Graph/Chart)
      • Factors Affecting the Market
      • Competitive Landscape in the Indian Flow Cytometry Market
    • Indian Electrophoresis Market - An Overview
      • Key Growth Drivers of The Electrophoresis Market
      • Drug Production Requirements Boost Growth
      • Competitive Landscape
  • B. Market Analytics
    • Table 49: Indian Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 50: Indian Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 51: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 52: Rest of Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

6. MIDDLE EAST & AFRICA

  • Market Analysis
    • Table 53: Middle East & African Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 54: Middle East & African Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

7. LATIN AMERICA

  • Market Analysis
    • Table 55: Latin American Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 56: Latin American Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 57: Latin American 14-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Revenues for Brazil and Rest of Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top